Cargando…
Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial
BACKGROUND: Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are antihyperlipidemic drugs with an established efficacy in stabilizing atherosclerotic plaques and preventing atherogenesis and reducing cardiovascular events. The purpose of this study was to determine the effect of simva...
Autores principales: | Mazidi, Mohsen, Rokni, Haleh, Sahebkar, Amir Hossein, Mohammadi, Akram, Ghayour-Mobarhan, Majid, Ferns, Gordon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910308/ https://www.ncbi.nlm.nih.gov/pubmed/27330686 http://dx.doi.org/10.4103/2008-7802.183652 |
Ejemplares similares
-
Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled
cross-over trial
por: Moohebati, Mohsen, et al.
Publicado: (2014) -
Effects of Simvastatin Treatment on Serum Adiponectin Concentrations in Patients With Dislipidemia
por: Moezzi, Atefeh, et al.
Publicado: (2014) -
Vitamin D, the gut microbiome and inflammatory bowel disease
por: Tabatabaeizadeh, Seyed-Amir, et al.
Publicado: (2018) -
Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial
por: Kermani, Tayyebeh, et al.
Publicado: (2015) -
Evaluation of serum cathepsin D concentrations in coronary artery disease
por: Mohammadpour, Amir Hooshang, et al.
Publicado: (2018)